Reirradiation of brain and skull base tumors with fractionated stereotactic radiotherapy

Int J Radiat Oncol Biol Phys. 1998 Mar 15;40(5):1151-5. doi: 10.1016/s0360-3016(97)00954-1.

Abstract

Purpose: We evaluated the feasibility of fractionated stereotactic radiotherapy for small intracranial recurrences after conventional radiotherapy.

Methods and materials: Nineteen patients who had initially undergone conventional radiotherapy to intracranial lesions, receiving a median total dose of 50 Gy in 5 weeks, were retreated with stereotactic radiotherapy for their recurrences and received a median total dose of 42 Gy in seven fractions over 2.3 weeks.

Results: Of the 19 patients, 15 achieved local control 3-51 months after reirradiation. No patient suffered from acute reaction, but one patient with a history of extensive radiotherapy developed progressive radionecrosis 9 months after reirradiation.

Conclusions: Fractionated stereotactic radiotherapy of intracranial recurrences appears to be effective in achieving in local control with negligible morbidity. We believe it merits further investigation in a prospective study.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Brain Neoplasms / radiotherapy
  • Brain Neoplasms / surgery*
  • Child
  • Feasibility Studies
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local / radiotherapy
  • Neoplasm Recurrence, Local / surgery*
  • Radiosurgery*
  • Skull Base Neoplasms / secondary
  • Skull Base Neoplasms / surgery*